AFter just a brief weekend of research I think BOT is probably one of the bios that undervalued, not going to bore everyone but already has revenue, FDA mid update is due anytime... i am biased because I hold a chunk, but have a read of the news to come, should do well this year.
I know this is a DT thread... but today is slow
Morning Trading March 13, page-85
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)